This document provides treatment guidelines for liver abscesses. It lists the typical pathogens that cause liver abscesses and recommends preferred and alternate intravenous (IV) therapy options as well as oral (PO) therapy or IV-to-PO switch options. The preferred IV therapy for aerobic gram-negative bacteria, enterococci, and B. fragilis is piperacillin-tazobactam or tigecycline. Alternate IV therapies include quinolones plus metronidazole or clindamycin. Once the abscess decreases in size on scans, patients can be switched to oral amoxicillin-clavulanic acid, moxifloxacin, or quinolone
This document provides treatment guidelines for liver abscesses. It lists the typical pathogens that cause liver abscesses and recommends preferred and alternate intravenous (IV) therapy options as well as oral (PO) therapy or IV-to-PO switch options. The preferred IV therapy for aerobic gram-negative bacteria, enterococci, and B. fragilis is piperacillin-tazobactam or tigecycline. Alternate IV therapies include quinolones plus metronidazole or clindamycin. Once the abscess decreases in size on scans, patients can be switched to oral amoxicillin-clavulanic acid, moxifloxacin, or quinolone
This document provides treatment guidelines for liver abscesses. It lists the typical pathogens that cause liver abscesses and recommends preferred and alternate intravenous (IV) therapy options as well as oral (PO) therapy or IV-to-PO switch options. The preferred IV therapy for aerobic gram-negative bacteria, enterococci, and B. fragilis is piperacillin-tazobactam or tigecycline. Alternate IV therapies include quinolones plus metronidazole or clindamycin. Once the abscess decreases in size on scans, patients can be switched to oral amoxicillin-clavulanic acid, moxifloxacin, or quinolone
Pathogens IV Therapy IV-to-PO Switch Therapy Liver Aerobic Piperacillin/ Quinolone† (IV)* Amoxicillin/clavulanic abscess GNBs tazobactam plus either acid 875/125 mg (PO) Enterococci 3.375 gm Metronidazole 1 gm q12h* (VSE) B (IV) q6h* (IV) q24h* or fragilis or or Moxifloxacin 400 mg Tigecycline Clindamycin 600 mg (PO) q24h* 100 mg (IV) (IV) q8h* or combination × 1 dose, Moxifloxacin 400 therapy then 50 mg mg with (IV) q12h* (IV) q24h* Quinolone† (PO)* or or plus either Meropenem Sulbactam/ampicillin Metronidazole 500 mg 1 gm 3 gm (IV) q6h (PO) q12h* (IV) q8h* or or Clindamycin 300 mg (PO) q8h* E histolytica See p 274 Duration of therapy represents total time IV, PO, or IV + PO * Treat until abscess(es) are no longer present or stop decreasing in size on serial CT scans † Ciprofloxacin 400 mg (IV) or 500 mg (PO) q12h or Levofloxacin 500 mg (IV or PO) q24h
Abses Liver
Jenis Patogen Rekomendasi Terapi Alternatif Terapi alternatif
Penyakit Terapi (I.V) (I.V) (P.O) Abses Aerobic GNBs Piperacillin/ Quinolone (.IV) Amoxicillin (asam Liver Enterococci tazobaktam plus either klavulanat) (VSE) B fragilis 3.375 gr Metronidazole 1 gr 875/125 mg (P.O) / (I.V)/6 jam (I.V)/24 jam 12 jam atau atau atau Tigecycline 100 Clindamycin 600 mg Moxifloxacin 400 mg (I.V) dosis (I.V)/8 jam mg (P.O)/24 jam tunggal, Moxifloxacin 400 atau terapi dilanjutkan 50 mg kombinasi mg (I.V)/24 jam Quinolone (P.O) (I.V)/12 jam atau tambah Meropenem 1 Ampicillin Metronidazole 500 gm sulbaktam 3 gr mg (I.V)/8 jam (I.V)/6 jam (P,O)/12 jam atau Clindamycin 300 mg (P.O)/8 jam